Please join us for an interactive session on how young startups should approach strategic partnering. Ben Schlatka, Co-founder and SVP of Corporate Development for MC10, a leading digital health company, will discuss the process and value of strategic equity investments, early-stage product development deals, IP licensing and capability building deals.
Participants will then engage in several live case studies and practice basic deal mechanics. MC10 has raised approximately $100M in private equity and has partnered with leading consumer and healthcare brands including Reebok/Adidas, L'Oreal, Medtronic, and LabCorp.
Benjamin Schlatka
Co-Founder & SVP of Corporate Development
Ben’s passion for growing and leading science based businesses led him to co-found MC10 in 2008. His multidisciplinary expertise in both material science and electronics uniquely position him to lead MC10’s partnership activities and growth across its Medical, Consumer, and Government segments. Ben’s career has been spent scaling technology enabled businesses. Prior to MC10, Ben helped grow Nantero’s carbon nanotube electronics business (sold to Lockheed Martin Corporation) and led marketing and sales for a Volunteer Solutions.org (winner 1998 MIT 50K, sold to the United Way). He began his career as a corporate intraprenuer as one of the founding team members of IBM’s Networking Hardware microelectronics business – today greater than a billion dollars in sales. Ben has been an invited key note speaker at Fortune 100 companies on strategies for growing disruptive science driven innovations. Ben’s other passion is coaching individuals on building their careers in technology and he serves as an executive coach at the Harvard Business School. Ben earned an MBA from the Harvard Business School and holds 2 issued patents with 11 pending.
